The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd. Affected intermediaries, who are not implicated in the supply chain breaches but who may have supplied dispensing practices, include:
- Smartway Pharmaceuticals Limited
- Drugsrus Limited
- Optimal Pharma Limited
Affected items include: Eliquis, Flutiform, Seretide Evohaler, Symbicort Turbohaler and Tysabri. View the full list.
To identify affected product, dispensing practices without FMD equipment should consider using the unique serial number (SN) and/or product code (PC)/Global Trade Item Number (GTIN) information available on the outer packaging of the product. Dispensaries should quarantine all remaining stock and hold it pending further instruction from the relevant supplier.
- GL Pharma is recalling one batch of Oxylan 40mg prolonged-release tablets (oxycodone hydrochloride) due to out of specification results for dissolution during routine stability testing.
The affected batch is as follows:
|Batch Number||Expiry Date||Pack Size||First Distributed|
Dispensary teams are asked to quarantine all stock for return to your supplier.